ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VPH Valeo Pharma Inc

0.11
-0.045 (-29.03%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Valeo Pharma Inc TSX:VPH Toronto Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.045 -29.03% 0.11 0.11 0.14 0.17 0.10 0.17 315,469 21:23:06

VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST

07/06/2023 12:00pm

PR Newswire (Canada)


Valeo Pharma (TSX:VPH)
Historical Stock Chart


From Jun 2022 to Jun 2024

Click Here for more Valeo Pharma Charts.

MONTREAL, June 7, 2023 /CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE:VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it will report its financial results and highlights for the second quarter ended April 30, 2023 on Tuesday June 13, 2023 after market close. The Company will host a conference call to discuss those results and highlights on Wednesday June 14, 2023 at 8.30am (ET).

Valeo Pharma Logo (CNW Group/Valeo Pharma Inc.)

To join the conference call without operator assistance, you may register and enter your phone number at https://emportal.ink/3MQ63Vs to receive an instant automated call back.

You can also dial direct to be entered to the call by an Operator. (Traditional conference call instructions here): 

Conference ID:                   

85029860

Date:                                   

Wednesday, June 14, 2023

Time:                                   

8:30am ET

Dial-in numbers:                 

1-888-664-6392 or 416-764-8659

Audio replay numbers:     

1-888-390-0541 or 416-764-8677

Replay code:                                   

029860 #

A live audio webcast of the conference call will be available via:
https://app.webinar.net/n3Z7jMNQv9N

About Valeo Pharma Inc.

Valeo Pharma is a fast growing Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory/Allergy, Ophthalmology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.

Forward Looking Statements

This press release contains forward-looking statements about Valeo's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate.

SOURCE Valeo Pharma Inc.

Copyright 2023 Canada NewsWire

1 Year Valeo Pharma Chart

1 Year Valeo Pharma Chart

1 Month Valeo Pharma Chart

1 Month Valeo Pharma Chart

Your Recent History

Delayed Upgrade Clock